PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.78
Bid: 42.66
Ask: 42.76
Change: -0.38 (-0.88%)
Spread: 0.10 (0.234%)
Open: 42.16
High: 43.04
Low: 42.16
Prev. Close: 43.16
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Jan 2021 10:03

RNS Number : 7587K
Assura PLC
06 January 2021
 

6 January 2021

Assura plc

("the Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that on 5 January 2021 the following named PDMRs acquired partnership shares and were awarded matching share awards over ordinary shares of 10 pence each in the Company under the Company's Share Incentive Plan ("SIP").

PDMR

Position

Number of partnership shares acquired

Number of matching shares awarded

Shareholding of PDMR and PCAs post acquisition and award

Jonathan Murphy

CEO

195

228

2,426,509

Jayne Cottam

CFO

195

228

175,961

Orla Ball

Company Secretary

195

228

2,333

 

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.7796 GBP

 

 

423

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.7796 GBP

 

 

423

 

£329.77 GBP

e)

Date of the transaction

 

5/01/2021

f)

Place of the transaction

 

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jayne Cottam

2

Reason for the notification

 

a)

Position/status

 

CFO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.7796 GBP

 

 

423

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.7796 GBP

 

 

423

 

£329.77 GBP

e)

Date of the transaction

 

5/01/2021

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Orla Ball

2

Reason for the notification

 

a)

Position/status

 

Company Secretary

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.7796 GBP

 

 

423

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.7796 GBP

 

 

423

 

£329.77 GBP

e)

Date of the transaction

 

5/01/2021

f)

Place of the transaction

 

XLON

 

 

 

For more information, please contact:

Assura plcOrla Ball, Company SecretaryDavid Purcell, Head of Investor Relations

Tel: 01925 420680Email: Investor@assura.co.uk

Finsbury

Gordon SimpsonJames Thompson

Tel: 0207 251 3801Email: Assura@Finsbury.com

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGGDBBGGDGBL
Date   Source Headline
15th Jun 20213:30 pmRNSHolding(s) in Company
11th Jun 20215:24 pmRNSHolding(s) in Company
10th Jun 20213:03 pmRNSHolding(s) in Company
8th Jun 20214:27 pmRNSDirector/PDMR Shareholding
4th Jun 20217:00 amRNSAnnual Report & Notice of AGM
3rd Jun 20214:03 pmRNSHolding(s) in Company
3rd Jun 20218:38 amRNSDirector/PDMR Shareholding
3rd Jun 20217:00 amRNSNotice of Dividend
2nd Jun 20217:00 amRNSDevelopment update
27th May 20218:55 amRNSHolding(s) in Company
18th May 20211:03 pmRNSHolding(s) in Company
18th May 20217:00 amRNSAssura Full Year Results 2021
7th May 20211:24 pmRNSDirector/PDMR Shareholding
4th May 20218:08 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSTotal Voting Rights
22nd Apr 20217:00 amRNSNotice of Results
16th Apr 202110:01 amRNSDirector/PDMR Shareholding
12th Apr 20217:00 amRNSScrip Dividend Declaration
8th Apr 20217:00 amRNSAdditional Listing
7th Apr 20214:09 pmRNSDirector/PDMR Shareholding
6th Apr 20217:00 amRNSDirectorate Change
31st Mar 20218:47 amRNSHolding(s) in Company
25th Mar 20214:05 pmRNSHolding(s) in Company
22nd Mar 20217:50 amRNSHolding(s) in Company
18th Mar 202111:50 amRNSScrip Calculation Price
9th Mar 20212:16 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSInvestor Presentation
8th Mar 202110:05 amRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSNotice of Dividend
19th Feb 20217:00 amRNSAcquisition of Apollo
11th Feb 20214:25 pmRNSExercise of Nil Cost Options under PSP
11th Feb 20211:31 pmRNSHolding(s) in Company
8th Feb 20213:13 pmRNSDirector/PDMR Shareholding
5th Feb 20219:18 amRNSAdditional Listing
26th Jan 20213:47 pmRNSHolding(s) in Company
18th Jan 20213:57 pmRNSDirector/PDMR Shareholding
11th Jan 20217:00 amRNSScrip Dividend Declaration
11th Jan 20217:00 amRNSTrading Update
6th Jan 202112:18 pmRNSDirector/PDMR Shareholding
6th Jan 202110:03 amRNSDirector/PDMR Shareholding
17th Dec 20204:47 pmRNSScrip Calculation Price
16th Dec 20209:43 amRNSHolding(s) in Company
9th Dec 202010:42 amRNSDirector/PDMR Shareholding
8th Dec 20204:29 pmRNSHolding(s) in Company
3rd Dec 20207:00 amRNSNotice of Dividend
2nd Dec 20202:49 pmRNSHolding(s) in Company
1st Dec 20209:01 amRNSHolding(s) in Company
26th Nov 20203:23 pmRNSHolding(s) in Company
18th Nov 20205:33 pmRNSHolding(s) in Company
17th Nov 20207:00 amRNSInterim Results 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.